Diopter Technologies
Diopter Technologies is a medical device company focused on developing innovative therapeutic solutions for ophthalmic conditions, including drug delivery via advanced contact lenses and dissolvable amniotic membrane biopolymer devices for ocular surface injuries and post-surgical recovery. By integrating sustained drug delivery into wearable platforms, the company enhances warfighter capabilities through improved operational readiness, providing a "set-and-forget" treatment for infections and trauma that eliminates the need for frequent eye drops in high-intensity or austere field environments. For veterans, these technologies offer life-changing regenerative solutions for service-connected ocular trauma and chronic conditions, promoting faster tissue healing and improving patient compliance through convenient, non-surgical alternatives that restore visual acuity and long-term quality of life.
Industries
Nr. of Employees
small (1-50)
Products
A therapeutic contact lens embedded with medication, releasing controlled doses directly to the eye for targeted treatment of various eye diseases.
A contact lens composed of amniotic membrane material designed to dissolve, releasing bioactive factors for ocular surface healing and inflammation reduction.
A dual layer contact lens integrating amnion and bioresorbable polymer for therapeutic treatment of corneal and ocular wounds.
A contact lens capable of releasing a combination of three drugs to manage post-cataract surgery recovery.
A contact lens engineered for release of the antibiotic moxifloxacin to treat corneal infection and abrasions.
A therapeutic contact lens embedded with medication, releasing controlled doses directly to the eye for targeted treatment of various eye diseases.
A contact lens composed of amniotic membrane material designed to dissolve, releasing bioactive factors for ocular surface healing and inflammation reduction.
A dual layer contact lens integrating amnion and bioresorbable polymer for therapeutic treatment of corneal and ocular wounds.
A contact lens capable of releasing a combination of three drugs to manage post-cataract surgery recovery.
A contact lens engineered for release of the antibiotic moxifloxacin to treat corneal infection and abrasions.
Expertise Areas
- Ophthalmic drug delivery
- Contact lens-based therapeutics
- Ocular surface disease management
- Biomaterial engineering for eye care
Key Technologies
- Drug-eluting contact lens
- Dissolving amniotic membrane biopolymer
- Biocompatible polymers
- Combination device-drug delivery
Key People
News & Updates
Article detailing the upcoming presentation and the technical overview of the dissolving biopolymer device.
Article summarizing the clinical study completion and technology background for the dissolving therapeutic lens.
Coverage of drug delivery technology presentation at a major vision research event.
Presentation of a dissolving biopolymer amniotic membrane device for ocular wound treatment at MedDevice Boston.
Announcement of successful completion of a clinical study evaluating a dissolving contact lens for ocular surface disease.
Showcased new ocular drug delivery technology at a Department of Defense forum dedicated to vision injury research.
Article detailing the upcoming presentation and the technical overview of the dissolving biopolymer device.
Article summarizing the clinical study completion and technology background for the dissolving therapeutic lens.
Coverage of drug delivery technology presentation at a major vision research event.
Presentation of a dissolving biopolymer amniotic membrane device for ocular wound treatment at MedDevice Boston.
Announcement of successful completion of a clinical study evaluating a dissolving contact lens for ocular surface disease.
Showcased new ocular drug delivery technology at a Department of Defense forum dedicated to vision injury research.